Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AMBIEN safely and effectively. See full prescribing information for AMBIEN. Ambien® (zolpidem tartrate) tablets CIV Initial U.S. Approval: 1992
Medication labelWhy this: Advisory · dailymed-prescription
Ambien (zolpidem tartrate) is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Ambien has been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see Clinical Studies (14)]. The clinical trials performed in support of efficacy were 4–5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment.
- generic_name
- zolpidem tartrate
- product_names
- zolpidem tartrate
- ndc
- 21695-211, 0024-5401, 21695-211-15, 21695-211-30, 21695-212, 0024-5421, 21695-212-15, 21695-212-30, 21695-212-45
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en